Leishmaniasis is a disease caused by protozoan parasites of genus Leishmania. The frequent involvement of Leishmania tropica in human leishmaniasis has been recognized only recently. Similarly as L. major, L. tropica causes cutaneous leishmaniasis in humans, but can also visceralize and cause systemic illness. The relationship between the host genotype and disease manifestations is poorly understood because there were no suitable animal models.
We studied susceptibility to L. tropica, using BALB/c-c-STS/A (CcS/Dem) recombinant congenic (RC) strains, which differ greatly in susceptibility to L. major. Mice were infected with L. tropica and skin lesions, cytokine and chemokine levels in serum, and parasite numbers in organs were measured.
Females of BALB/c and several RC strains developed skin lesions. In some strains parasites visceralized and were detected in spleen and liver. Importantly, the strain distribution pattern of symptoms caused by L. tropica was different from that observed after L. major infection. Moreover, sex differently influenced infection with L. tropica and L. major. L. major-infected males exhibited either higher or similar skin pathology as females, whereas L. tropica-infected females were more susceptible than males. The majority of L. tropica-infected strains exhibited increased levels of chemokines CCL2, CCL3 and CCL5. CcS-16 females, which developed the largest lesions, exhibited a unique systemic chemokine reaction, characterized by additional transient early peaks of CCL3 and CCL5, which were not present in CcS-16 males nor in any other strain.
Comparison of L. tropica and L. major infections indicates that the strain patterns of response are species-specific, with different sex effects and largely different host susceptibility genes.
Several hundred million people are exposed to the risk of leishmaniasis, a disease caused by intracellular protozoan parasites of several Leishmania species and transmitted by phlebotomine sand flies. In humans, L. tropica causes cutaneous form of leishmaniasis with painful and long-persisting lesions in the site of the insect bite, but the parasites can also penetrate to internal organs. The relationship between the host genes and development of the disease was demonstrated for numerous infectious diseases. However, the search for susceptibility genes in the human population could be a difficult task. In such cases, animal models may help to discover the role of different genes in interactions between the parasite and the host. Unfortunately, the literature contains only a few publications about the use of animals for L. tropica studies. Here, we report an animal model suitable for genetic, pathological and drug studies in L. tropica infection. We show how the host genotype influences different disease symptoms: skin lesions, parasite dissemination to the lymph nodes, spleen and liver, and increase of levels of chemokines CCL2, CCL3 and CCL5 in serum.
Citation: Kobets T, Havelková H, Grekov I, Volkova V, Vojtíšková J, Slapničková M, et al. (2012) Genetics of Host Response to Leishmania tropica in Mice – Different Control of Skin Pathology, Chemokine Reaction, and Invasion into Spleen and Liver. PLoS Negl Trop Dis 6(6): e1667. doi:10.1371/journal.pntd.0001667
Editor: Christian R. Engwerda, Queensland Institute of Medical Research, Australia
Received: November 11, 2011; Accepted: April 17, 2012; Published: June 5, 2012
Copyright: © 2012 Kobets et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Czech Science Foundation (http://www.gacr.cz/international.htm) (grant nos. 310/08/1697 and 310/08/H077), the Academy of Sciences of the Czech Republic (http://www.cas.cz/) (project grant no. RVO 68378050), and the Ministry of Education of the Czech Republic (http://www.msmt.cz/index.php?lang=2) (project grant LC 06009). The PhD study of I. Kurey, V. Volkova and Y. Sohrabi is supported in part by the 3rd Faculty of Medicine, Charles University in Prague (http://www.lf3.cuni.cz/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Several hundred million people in 88 countries are living in areas where they can contract leishmaniasis, a disease caused by intracellular protozoan parasites of the genus Leishmania and transmitted to vertebrates by phlebotomine sand flies. Leishmania parasites infect professional phagocytes (neutrophils, monocytes and macrophages), as well as dendritic cells and fibroblasts . The main vertebrate host target cell is the macrophage, where parasites multiply, eventually rupture the cell, and spread to uninfected cells . As macrophages migrate to all mammalian tissues, Leishmania parasites have a great potential for damaging bodily functions. In the dermis, they cause the cutaneous form of the disease (which can be localized or diffuse); in the mucosa, they result in mucocutaneous leishmaniasis; and the metastatic spread of infection to the spleen and liver leads to visceral leishmaniasis. One of the major factors determining the type of pathology is the species of Leishmania . However, the transmitting vector, as well as genotype, nutritional status of the host, and environmental and social factors also have a large impact on the outcome of the disease , . That is why even patients, infected by the same species of Leishmania, develop different symptoms  and may differ in their response to therapy . The basis of this heterogeneity is not well understood , but part of this variation is likely genetic. Numerous potentially relevant genes were reported (reviewed in ).
The extent of involvement of Leishmania tropica in human leishmaniasis has been recognized only recently. The western limit of L. tropica appears to be the Greek Island of Zakynthos, the disease has been found in Turkey, Syria, Jordan, Israel, Morocco, Tunisia, Saudi Arabia, Yemen, Iran, Iraq, Afghanistan, Turkmenistan, Pakistan, Kenya, Ethiopia and Namibia, and at its eastern limits in India (reviewed in ). While L. major is a zoonosis with mainly rodent (Gerbillidae) reservoir hosts, L. tropica can circulate among humans without the involvement of animal reservoirs, but zoonotic transmission also occurs . Similarly to L. major, L. tropica causes cutaneous leishmaniasis in humans. Moreover, L. tropica was also reported to visceralize and cause an initially not understood systemic illness in veterans returning from endemic areas in the Middle East , as well as the classical visceral leishmaniasis (kala-azar) in India , and the disseminated cutaneous leishmaniasis accompanied with visceral leishmaniasis in Iran .
A suitable animal model for study of this parasite would contribute to functional dissection of the clinical course of infection. Golden hamsters (Mesocricetus auratus) have been considered to be the best model host of the L. tropica infection, but this host is not inbred and hence not suitable for many studies. However, several strains of L. tropica from Afghanistan, India , and Turkey  have been described to cause cutaneous disease in inbred BALB/c mice, thus providing a better defined host. In comparison with widely studied immune response to L. major infection (reviewed in ) and its genetic control (reviewed in ), little is known about L. tropica in mouse , , . Here we aimed to study genetics of susceptibility to L. tropica in the mouse. We analyzed response to L. tropica in CcS/Dem (CcS) recombinant congenic (RC) strains  derived from the background strain BALB/cHeA (BALB/c) and the donor strain STS. Each CcS strain contains a different unique random set of about 12.5% genes from the donor strain STS and 87.5% genes from the background strain BALB/c. These strains have been already successfully used for analysis of infection with Leishmania major –. The RC system enabled us to analyze organ pathology and systemic disease after infection with L. tropica and their genetic control.
Materials and Methods
Males and females of strains BALB/c, STS and selected RC strains ,  were tested. When used for these experiments, RC strains were in more than 38 generation of inbreeding and therefore highly homozygous. During the experiment, male and female mice were placed into separate rooms and males were caged individually. The research had complied with all relevant European Union guidelines for work with animals and was approved by the Institutional Animal Care Committee of the Institute of Molecular Genetics AS CR and by Departmental Expert Committee for the Approval of Projects of Experiments on Animals of the Academy of Sciences of the Czech Republic.
Experiments with Leishmania tropica.
Mice of the strains BALB/c (12 females, 12 males), STS (12 females, 13 males), CcS-3 (12 females, 10 males), CcS-5 (11 females, 12 males), CcS-11 (14 females, 19 males), CcS-12 (6 females, 6 males), CcS-16 (12 females, 12 males), CcS-18 (8 females, 12 males), and CcS-20 (12 females, 12 males) were infected with L. tropica. Mice were tested in 2 successive experimental groups and were killed 21 and 43 weeks after infection. The age of the mice at the time of infection was 9 to 26 weeks (mean 16 weeks, median 16 weeks).
Experiments with Leishmania major.
Mice of the strains BALB/c (27 females, 30 males), STS (8 females, 10 males), CcS-3 (10 females, 10 males), CcS-5 (26 females, 32 males), CcS-11 (20 females, 21 males), CcS-12 (18 females, 17 males), CcS-16 (11 females, 13 males), CcS-18 (9 females, 4 males), and CcS-20 (14 females, 18 males) were infected with L. major. Mice were tested in 8 successive experimental groups and were killed 8 weeks after infection. The age of the mice at the time of infection was 8 to 47 weeks (mean 16 weeks, median 15 weeks).
Leishmania tropica from Urfa, Turkey (MHOM/1999/TR/SU23) was used for infecting mice. Amastigotes were transformed to promastigotes using SNB-9 , 1×107 stationary phase promastigotes from subculture 2 have been inoculated in 50 µl of sterile saline s.c. into the tail base, with promastigote secretory gel (PSG) collected from the midgut of L. tropica-infected Phlebotomus sergenti females (laboratory colony originating from L. tropica focus in Urfa). PSG was collected as described . The amount corresponding to one sand fly female was used per mouse.
Leishmania major LV 561 (MHOM/IL/67/LRC-L137 JERICHO II) was used for mouse infection. Amastigotes were transformed to promastigotes using SNB-9 , 1×107 promastigotes from 6 days old subculture 2 were inoculated in 50 µl of sterile saline s.c. into the tail base.
The size of the skin lesions was measured weekly using a Vernier caliper gauge. The mice infected with L. tropica were killed 21 or 43 weeks after inoculation. Mice infected with L. major were killed 8 weeks after infection. Blood, spleen, liver and inguinal lymph nodes were collected for further analysis.
Quantification of parasite load in spleens and inguinal lymph nodes
The current semi-quantitative technique is based on the limiting dilution assay . We modified the procedure by using only a single pre-selected cell concentration, and parasite count was measured with a Coulter Counter CBC5 (Coulter Electronics Inc., Hialeah, FL). In comparison with the original limiting dilution technique, this modified culture method is less laborious and allows rapid estimation of parasite number.
Preparation of cells must be carried out under sterile conditions. During preparation, all samples, which were not immediately worked with, were kept on ice. Inguinal lymph nodes and quarters of spleens were disrupted in a glass homogenizer in complete RPMI (containing 5% of heat-inactivated fetal calf serum (Sigma-Aldrich, USA), 25 mM Hepes (Sigma-Aldrich, USA), 0.0005% β-mercaptoethanol (Serva, Germany), 63.7 µg/ml penicillin (Sigma-Aldrich, USA), and 100 µg/ml streptomycin (Sigma-Aldrich, USA). The homogenate was passed through the nylon filter. The homogenizer was washed 3 times with 3 ml of sterile PBS after processing each lymph node. The samples were then centrifuged 8 min at 300 g, 4°C (centrifuge Eppendorf 5810 R, Eppendorf, Germany). The supernatant was removed and the cells were resuspended in 0.5 ml of complete Schneider's medium supplemented with 20% heat-inactivated fetal calf serum (Sigma-Aldrich, USA), 2% sterile fresh human urine, 50 µg/ml gentamicine (Sigma-Aldrich, USA), 63.7 µg/ml penicillin (Sigma-Aldrich, USA), and 100 µg/ml streptomycin (Sigma-Aldrich, USA). To count cells with a Coulter Counter CBC5 (Coulter Electronics Inc., Hialeah, FL), USA), 50 µl of the cell suspension was diluted in 20 ml of PBS. Ekoglobin (Hemax s.r.o., Czech Republic) was added to the diluent prior to counting to lyse red blood cells.
0.5 ml of the cell suspension (1×105 cells per ml for lymph nodes and 2×105 cells per ml for spleens) was cultivated in complete Schneider's medium in 48-well tissue culture plates (Costar, Corning Inc., USA) at 27°C (Biological thermostat BT 120 M, Labsystem, Finland) for 3 days. Each sample was prepared in triplicate. After incubation, 100 µl of a mixed sample from each well, containing Leishmania parasites released from lymph node or spleen cells were diluted in 20 ml of PBS and the parasite number was counted with the Coulter Counter.
Quantification of parasite load in livers
Parasite load was measured in frozen liver samples using PCR-ELISA according to the previously published protocol . Briefly, total DNA was isolated using a standard proteinase procedure. For PCR, two primers (digoxigenin-labeled F 5′-ATT TTA CAC CAA CCC CCA GTT-3′ and biotin-labeled R 5′-GTG GGG AGG GGG CGT TCT-3′ (VBC Genomics Biosciences Research, Austria) were used for amplification of the 120-bp conservative region of the kinetoplast minicircle of Leishmania parasite, and 50 ng of extracted DNA was used per each PCR reaction. For a positive control, 20 ng of L. tropica DNA per reaction was amplified as a highest concentration of standard. A 40-cycle PCR reaction was used for detection. Parasite load was determined by analysis of the PCR product with the modified ELISA protocol (Pharmingen, USA). Concentration of Leishmania DNA was determined using the ELISA Reader Tecan and the curve fitter program KIM-E (Schoeller Pharma, Czech Republic) with least squares-based linear regression analysis.
Cytokine and IgE levels
Levels of GM-CSF (granulocyte-macrophage colony-stimulating factor), CCL2 (chemokine ligand 2)/MCP-1 (monocyte chemotactic protein-1), CCL3/MIP-1α (macrophage inflammatory protein-1α), CCL4/MIP-1β (macrophage inflammatory protein-1β), CCL5/RANTES (regulated upon activation, normal T-cell expressed, and secreted) and CCL7/MCP-3 (monocyte chemotactic protein-3) in serum were determined using Mouse chemokine 6-plex kit (Bender MedSystems, Austria). The kit contains two sets of beads of different size internally dyed with different intensities of fluorescent dye. The set of small beads was used for GM-CSF, CCL5/RANTES and CCL4/MIP-1β and the set of large beads for CCL3/MIP-1α, CCL2/MCP-1 and CCL7/MCP-3. The beads are coated with antibodies specifically reacting with each of the analytes (chemokines) to be detected in the multiplex system. A biotin secondary antibody mixture binds to the analytes captured by the first antibody. Streptavidin-phycoerythrin binds to the biotin conjugate and emits a fluorescent signal. The test procedure was performed in the 96 well filter plates (Millipore, USA) according to the protocol of Bender MedSystem. Beads were analyzed on flow cytometer LSR II (BD Biosciences, USA). As standards were used lyophilized GM-CSF and chemokines (CCL2/MCP-1, CCL3/MIP1α, CCL4/MIP1β, CCL5/RANTES, CCL7/MCP-3) supplied in the kit. Concentration was evaluated by Flow Cytomix Pro 2.4 software (eBioscience, Vienna, Austria). The limit of detection of each analyte was determined to be for GM-CSF 12.2 pg/ml, CCL2/MCP-1 42 pg/ml, CCL7/MCP-3 1.4 pg/ml, CCL3/MIP-1α 1.8 pg/ml, CCL4/MIP-1β 14.9 pg/ml, CCL5/RANTES 6.1 pg/ml respectively.
IFNγ, IL-4, IL-12 and IgE levels in serum were determined using the primary and secondary monoclonal antibodies (IFNγ: R4-6A2, XMG1.2; IL-4: 11B11, BVD6-24G2; IL-12p40/p70: C15.6, C17.8; IgE: R35-72, R35118) and standards from BD Biosciences, USA (recombinant mIFNγ, mIL-4, mIL-12 and purified mIgE: C38-2). ELISA was performed as recommended by BD Biosciences. The ELISA measurement of IFNγ, IL-4, IL-12, and IgE levels was performed by the ELISA Reader Tecan and the curve fitter program KIM-E (Schoeller Pharma, Czech Republic) using least squares-based linear regression analysis. The detection limit of ELISA was determined to be 30 pg/ml for IFNγ, 8 ng/ml for IgE, 16 pg/ml for IL-4 and 15 pg/ml for IL-12.
Staining of tissue sections
Inguinal lymph nodes and spleens were fixed in 4% formaldehyde and embedded in paraffin. Immunohistochemical staining of parasites was performed in 5 µm lymph node sections. Slides were deparaffinized with xylene (2 times for 5 min) and rehydrated with 96% ethanol (3 times for 3 min), 80% ethanol (3 min), 70% ethanol (3 min) and PBS (phosphate buffer saline, 3 min). Endogenous peroxidase was quenched with 3% H2O2 in methanol for 10 min. Sections were washed in PBS (10 min) and parasites were stained using anti-Leishmania lipophosphoglycan monoclonal mouse IgM (Code Nr. CLP003A, Cedarlane, Canada) diluted 1:100 in PBS with 1% BSA (bovine serum albumine, Sigma-Aldrich, USA) and applied for 1 h at 37°C, followed by TRITC-conjugated goat anti-mouse IgM (Code Nr. 115-025-020, Jackson Immunoresearch, USA), also diluted 1:100 in PBS with 1% BSA and applied for 1 h at 37°C. Cell nuclei were stained with DAPI (4′,6-diamidino-2-phenylindole dihydrochloride) 10 ng/µl (Sigma-Aldrich, USA). For histological analysis, 5 µm spleen and lymph node sections were stained by the routine hematoxylin and eosin method (H&E).
The differences between CcS/Dem strains in parasite numbers in lymph nodes were evaluated by the analysis of variance (ANOVA) and Newman-Keuls multiple comparison using the program Statistica for Windows 8.0 (StatSoft, Inc., Tulsa, Oklahoma, U.S.A.). Strain and age were fixed factors and individual experiments were considered as a random parameter. The differences in parameters between strains were evaluated using the Newman-Keuls multiple comparison test at 95% significance. Difference between sexes in parasite numbers in lymph nodes was analysed by Mann Whitney U test. Analysis of sex influence on lesion development after L. major infection was performed using General Linear Models, Univariate ANOVA, Statistica 8.0 with experiment as a random and age as a fixed parameter.
Genetic differences in skin pathology caused by infection with L. tropica
To study susceptibility to L. tropica we infected both females and males of the strains BALB/c, STS and RC strains CcS-3, CcS-5, CcS-11, CcS-12, CcS-16, CcS-18, and CcS-20.
In females, skin pathology started as a nodule at the site of L. tropica infection appearing between weeks 11 and 20, which transformed in susceptible strains into a skin lesion (Figure 1). Females of the strains BALB/c, CcS-11, CcS-16 and CcS-20 were relatively susceptible to the infection and developed skin lesions after week 18; the largest lesions were observed in CcS-16 (Figure 2A). Females of the strain CcS-16 exhibited skin lesions from week 18 until the end of experiment (week 43). In females of the strains BALB/c, CcS-11 and CcS-20, the lesions partly healed and tended to transform back to nodules after week 30. Interestingly, in females of the strain CcS-11, small skin nodules appeared at week 14, but at 32–42 weeks of infection half of the females died without obvious pathological findings. Only one female died at week 13 in the 21-week experiment. Strains CcS-12 and CcS-18 are intermediate in susceptibility to skin pathology. CcS-12 females developed small skin lesions at the late stages of infection (after week 37), whereas CcS-18 females developed nodules or small lesions that healed. Strains STS, CcS-3 and CcS-5 were resistant to skin lesions development. Females of the strain CcS-3 had small skin nodules at the late stages of infection and did not develop skin lesions during the entire course of the experiment. Females of the strains STS and CcS-5 were resistant to L. tropica, and only a few of them developed small nodules at the site of infection.
Individual strains are marked with different colors. The columns show median values of lesion size in females (A) and males (B). Figure summarizes data from two independent experiments.
Males of the strain CcS-16 developed small lesions from week 22, which later healed, whereas BALB/c males exhibited small lesions from week 30 until the end of the experiment (Figure 2B). Males of the strain CcS-12 developed small skin lesions at the late stages of infection (after week 37). Males of CcS-11 developed no or only small skin nodules, but most of the animals died before week 18 of infection. Similarly as CcS-11 females, they were without obvious pathological findings. Males of the strains STS, CcS-3 and CcS-5 had small skin nodules at the late stages of infection and did not develop skin lesions within the entire course of the experiment. Only a few males of the strains CcS-18 and CcS-20 developed small nodules at the site of infection.
Sex has different effect on skin pathology caused by L. tropica and L. major
Sex differences observed in susceptibility to L. tropica led us to analyze sex influence in susceptibility to L. major. As our previous research with L. major was focused on analysis of females , in this study we have infected with L. major both females and males of strains BALB/c, STS and RC strains CcS-3, CcS-5, CcS-11, CcS-12, CcS-16, CcS-18, and CcS-20. Both males and females of all analyzed strains developed larger skin lesions after infection with L. major than when infected with L. tropica (Table 1, Figure 2A, B). The effect of sex was different in experiments with L. major and L. tropica. After the infection with L. tropica, females of CcS/Dem strains in most cases exhibited more extensive skin pathology than males (Figure 2 A, B), whereas after infection with L. major, skin lesions in males and females of strains BALB/c, STS, CcS-11, CcS-12, CcS-16 and CcS-20 did not differ, whereas males of strains CcS-3 (P = 0.001), CcS-5 (P = 0.001) and probably also CcS-18 (P = 0.043) developed larger skin lesions than females (Table 1).
Draining lymph nodes of all tested strains contained viable L. tropica parasites
In vitro culture tests showed that all tested mice, including strains that did not exhibit any skin pathology, contained viable parasites in their inguinal lymph nodes both 21 and 43 weeks after infection (Figure 3). Presence of parasites was also documented by staining of Leishmania in tissue smears with the anti-Leishmania lipophosphoglycan monoclonal antibody (Figure 4) and by histological analysis of hematoxylin-eosin stained lymph nodes smears (Figure S1).
Mice were killed at week 21 (A) and week 43 (B) after infection. Asterisks show strains that exhibited parasite load significantly different from BALB/c. Brackets indicate strains with differences between males and females. Data are presented as mean ± SD.
A smear of the inguinal lymph node of BALB/c male was stained with the anti-Leishmania lipophosphoglycan monoclonal antibody (CLP003A, Cedarlane, Hornby, Canada) and TRITC labeled IgM (115-025-020, Jackson Immunoresearch, West Grove, PA, United States of America), all diluted 1:100. Nuclei of the cells were stained with DAPI. Parasites are shown with arrows.
None of the strains contained more parasites in the lymph nodes than the background parental strain BALB/c (Figure 3). At week 21 after infection, females of the strains STS and CcS-5 (P = 0.0002), and males of the strain CcS-5 (P = 0.0093) contained significantly lower parasite numbers than the strain BALB/c. At week 43 after infection, females of the strains STS, CcS-5 and CcS-11 (P = 0.00000001), and STS males (P = 0.0004) had significantly lower parasite load than BALB/c. At week 43, females of strain CcS-18 had higher parasite count than males (P = 0.0209), whereas males of the strain CcS-5 had higher parasite load than females (P = 0.0143). In both experiments counted together, females of CcS-18 (P = 0.0318) strain had higher parasite load than males, whereas STS males had higher parasite numbers than females (P = 0.0097) (Figure 3).
L. tropica can invade spleens and livers of several mouse strains
We did not observe any splenomegaly and hepatomegaly induced by infection with L. tropica. However, in vitro cultures have shown that 21 weeks after infection 50% (3 out of 6), 66.7% (2 out of 3) and 16.7% (1 out of 6) spleens of female mice of the strains CcS-3, -18 and -20, respectively, contained viable parasites. We were also able to cultivate parasites from 16.7% (1 out of 6) and 33.3% (2 out of 6) of spleens of males of the strains BALB/c and CcS-20, respectively. Parasite presence in spleens was confirmed by histological examination (Figure 5). Parasite numbers in spleens of other strains were either below the level of detection or absent. Mice of the strain CcS-12 were not tested in the 21-week experiment.
Arrows show a group of parasites among spleen cells in infected BALB/c male (A); noninfected control BALB/c male without parasites (B).
Later we measured parasite load in frozen liver tissues using PCR-ELISA . The presence of parasites after 21 weeks of infection was detected in females of the strains BALB/c 33.33% (2 out of 6), CcS-3 66.67% (4 out of 6), CcS-11 42.86% (3 out of 7), CcS-16 71.43% (5 out of 7), CcS-18 66.67% (2 out of 3) and CcS-20 75% (3 out of 4). Livers of males of the same strains also contained parasites: BALB/c 83.33% (5 out of 6), CcS-3 100% (3 out of 3), CcS-11 80% (4 out of 5), CcS-16 66.67% (4 out of 6), CcS-18 33% (2 out of 6) and CcS-20 83.33% (5 out of 6).
Unfortunately, an additional analysis of spleens and lymph nodes with PCR-ELISA cannot be performed as these organs were completely used for the cultivation assay.
Systemic reactions after infection with L. tropica
We measured levels of IL-4, IL-12, IFNγ, GM-CSF (granulocyte-macrophage colony-stimulating factor), CCL2 (chemokine ligand 2)/MCP-1 (monocyte chemotactic protein-1), CCL3/MIP-1α (macrophage inflammatory protein-1α), CCL4/MIP-1β (macrophage inflammatory protein-1β), CCL5/RANTES (regulated upon activation, normal T-cell expressed, and secreted), CCL7/MCP-3 (monocyte chemotactic protein-3) and IgE in serum of uninfected and infected mice.
No significant difference was found in IL-4, IL-12, IgE, IFNγ and GM-CSF levels in serum of infected mice in comparison with noninfected controls (data not shown). We have observed an increase of serum levels of CCL2, CCL3 and CCL5 in infected strains; the largest increase was observed in strains CcS-11, CcS-16, CcS-18 and CcS-20. Figure 6 shows chemokine kinetics in females. Peak of increase of levels of these chemokines usually followed the start of lesion development. The increase was greater in females than in males (data not shown). Females of the strain CcS-16 exhibited a unique pattern of kinetics of CCL3 and CCL5 levels, which differed from all other strains (Figure 6) and also from CcS-16 males (Figure 7). We observed two peaks of increase of serum levels of CCL3 and CCL5 in females of CcS-16 (Figure 6); one before the development of skin lesions, the other after the decrease of lesion size, and there were almost no changes in CCL2 level. CcS-16 males had slight increase of CCL3, CCL5 (Figure 7), and CCL2 (data not shown); their kinetics of increase was similar to those in females and males of other strains.
Kinetics of skin lesion development (median, left y axis) and serum levels of CCL2, CCL3 and CCL5 (median values; right y axis) in females are shown. Figure summarizes data from two independent experiments (21 and 43 weeks of infection).
Kinetics of CCL3 levels (median values) in serum of BALB/c (A) and CcS-16 (B) and serum levels of CCL5 (median values) in BALB/c (C) and CcS-16 (D) mice is shown. Figure summarizes data from two independent experiments (21 and 43 weeks of infection).
We have analyzed manifestations of the disease and the immunological parameters, which constitute the pathology of leishmaniasis in mice (organ pathology, parasite load in organs, systemic immune response) after infection with L. tropica. Compared with infection with L. major, infection progressed more slowly, some manifestations (skin lesions, parasite load in organs) were less pronounced, some (splenomegaly, hepatomegaly) were absent in the tested strains, and the systemic immune response also differed. These observations reveal new areas where the comparative research of infection by the two species can contribute to a deeper genetic and functional understanding of responses to both and perhaps eventually lead to a common conceptual framework for their interpretation. Such more general scheme could not be readily obtained by analysis of any of them alone. A progress in the heavily under-investigated biology of responses to L. tropica infection may also have a translational potential, which may be significant in view of the recent wider recognition of the etiological role of this parasite in human disease. The areas highlighted by our results include the likely species specificity of at least some susceptibility genes, the dramatically different effects of sex on the response, and a different regulation of some systemic responses.
Genotype effects are different in L. tropica and L. major infection
We have observed clearly different patterns in strains' susceptibility to L. tropica and L. major. Out of the nine strains tested, four (BALB/c, STS, CcS-5, CcS-16) exhibited similar relative susceptibility, whereas susceptibility of five strains (CcS-3, CcS-11, CcS-12, CcS-18 and CcS-20) to these two parasites differed. Strains CcS-3 and CcS-20 are resistant and susceptible, respectively, to development of skin lesions after infection with L. tropica, but intermediate to infection with L. major. The strains CcS-12, CcS-18, and CcS-16 are among the most susceptible to L. major infection , (Table 1), whereas with L. tropica CcS-12 and CcS-18 are clearly less susceptible than BALB/c and CcS-16 (Figure 2). The mice of strain CcS-11 are intermediate after infection with L. major, but after infection with L. tropica they died with small or no lesions, low parasite load in lymph nodes and with no detectable parasites in spleens. The cause of mortality of CcS-11 was not revealed by standard histo-pathological investigation. These differences indicate presence of species-specific susceptibility genes. Such genes were indicated also by results of Anderson and coworkers  who found that strains BALB/c and C57BL/6 had similar numbers of parasites in ear dermis and exhibited similar ear lesion development after infection with L. tropica. In contrast, these two strains differ greatly in susceptibility to L. major , (reviewed in  and ). Poly-specific response genes that control susceptibility to both L. major and L. tropica probably also exist, as the strains STS and CcS-5 are resistant and BALB/c and CcS-16 are susceptible to cutaneous disease induced by both parasite species (Figure 2, Table 1).
These data complement information about species-specific and poly-specific control of infection to L. donovani, L. infantum, L. mexicana and L. major (reviewed in ). Poly-specific and species-specific susceptibility genes are not limited to leishmaniasis, but were also indicated in susceptibility to other pathogens such as Plasmodium (reviewed in ). The data on susceptibility to L. tropica and L. major reported here is relevant for investigators of other species-specific responses.
Females of the strain CcS-16 that contains a set of approximately 12.5% genes of the donor strain STS and 87.5% genes of the background strain BALB/c exhibited the largest skin pathology (Figure 1, Figure 2A), exceeding skin manifestations in both parental strains BALB/c and STS. The observations of progeny having a phenotype, which is beyond the range of the phenotype of its parents, are not rare in traits controlled by multiple genes. It was observed in different tests of immune responses of RC strains in vitro – and in vivo , . Similarly, analysis of gene expression from livers in chromosome substitution strains revealed that only 438 out of 4209 expression QTLs were inside the parental range . These observations are due to multiple gene-gene interactions of QTLs, which in new combinations of these genes in RC or chromosomal substitution strains can lead to the appearance of new phenotypes that exceed their range in parental strains. Alternatively, with traits controlled by multiple loci, parental strains often contain susceptible alleles at some of them and resistant at others, and some progeny may receive predominantly susceptible alleles from both parents. However, we cannot exclude the possibility that the unique phenotype of CcS-16 may be caused by a spontaneous mutation, which had appeared during the inbreeding, similarly as for example a loss-of-function mutation in pyruvate kinase protecting RC strains AcB55 and AcB61 against malaria, which is absent in both parental strains A/J and C57BL/6 .
The strains CcS-3 and CcS-5, which are resistant to L. tropica share common STS-derived segments on chromosome 5 (a small part near the position 131.01 Mb); chromosome 6 (segment 32- 44 Mb); chromosome 8 (0–14.72 Mb) and on chromosome 10 (114.44–125.42 Mb)( and unpublished data). Interestingly, the segment on chromosome 10 overlaps with Lmr5, which controls resistance to L. major .
Strong sex-genotype interaction after infection with L. tropica
Three phenomena related to sex influence on Leishmania infection deserve attention: i) a different sex influence on overall susceptibility to skin pathology after infection with relatively closely related pathogen species L. tropica and L. major (Figure 2, Table 1), ii) different sex influence on strains' susceptibility to development of skin lesions (Figure 2) and on parasite numbers in lymph nodes (Figure 3), and iii) sex influence on chemokine levels in serum (Figure 7).
In contrast to L. major infection in CcS/Dem RC strains where males exhibited either higher or similar pathology as females, in L. tropica experiments females were more susceptible to skin pathology than males. However, lymph nodes of females and males of most RC strains do not differ in L. tropica parasite load. The only exceptions are lymph nodes of the strains CcS-5 (and possibly STS), where males exhibit higher numbers of parasites than females and strain CcS-18, where females exhibit higher number of parasites than males (Figure 3). We have also observed a unique transient early peak of serum level of CCL3 and CCL5 in CcS-16 females, but not in CcS-16 males nor in any other strain (see the following section). These data suggest that some genes controlling susceptibility to L. tropica might be sex dependent or alternatively that this sex influence depends on genotype.
Different sex influence on susceptibility to L. mexicana and L. major was observed in DBA/2 mice where females were highly resistant and males susceptible to lesion development after infection with L. mexicana. On the contrary, although both female and male mice developed ulcerating lesions after infection with L. major, lesions healed in males but not in females . Sex influenced liver parasite burdens after intravenous inoculation of L. major in strains BALB/cAnPt, DBA/2N and DBA/2J, males having higher parasite load than females .
Genotype influence on sex differences was described in studies of L. major infection , . No sex differences in susceptibility were observed in BALB/cJ mice, whereas male B10.129(10 M)ScSn mice were relatively resistant to cutaneous disease, while females developed non-healing ulcerative lesions followed by parasites' metastases and death 
Comparison of L. major susceptibility in two strains, BALB/cHeA and CcS-11, has shown that there is no significant sex influence on skin lesion development, splenomegaly and hepatomegaly in these strains. Parasite numbers in lymph nodes in males of both strains were higher than in females; however in spleens only CcS-11 but not BALB/c males had higher numbers than females. These observations show that sex affects pathology of various organs differently and that this influence is modified by the host genotype .
These results indicate that data obtained with L. tropica (different sex influence on susceptibility to two relatively closely related pathogen species, sex and genotype interaction, and different sex influence on pathology in different organs) reflect a more general phenomenon. Other clear sex biases in incidence of disease, parasite burden, pathology, mortality, and immunological response against various parasites, have been observed in humans and in rodents (reviewed in ).
Systemic reactions and a unique pattern of chemokine response in CcS-16 females, but not males of CcS-16
No significant difference was found in IL-4, IL-12, IFNγ and GM-CSF levels in serum of infected mice in comparison with noninfected controls (data not shown). This differs from increase of serum levels of IL-4, IFNγ and IL-12 observed in CcS/Dem strains after 8 weeks of infection . Loci controlling serum levels of IL-4, IFNγ, IL-12, TNFα and IL-6 after 8 weeks of L. major infection are described in , , . Similarly as after L. tropica infection, no increase was observed in serum GM-CSF level after infection with L. major (data not shown).
However, the absence of differences in serum levels of IL-4, IL-12, IFNγ and GM-CSF after infection does not exclude the possibility that they are involved in the local response to L. tropica. To test this alternative future experiments are needed, similar to those performed to establish the role of Fli1 (Friend leukemia integration 1) in L. major infection model .
Infection with L. tropica led to increased serum levels of chemokines CCL2, CCL3 and CCL5. The highest increase was observed in the strains CcS-11, CcS-16, CcS-18, and CcS-20 (Figure 6, chemokine kinetics in females). The most prominent was the increase of CCL3/MIP-1α. Unexpectedly and in contrast with the other strains tested, the CcS-16 females but not males exhibited a unique pattern of this systemic reaction, characterized by an additional early peak of chemokine levels before the onset of cutaneous disease. It suggests that these early peaks of CCL3 and CCL5 (Figure 7) might be associated with an increased susceptibility of CcS-16 females to L. tropica. However, they could also reflect a stronger, but ineffective response.
CCL3 is produced by a range of cell types, including monocytes/macrophages, lymphocytes, mast cells, basophils, epithelial cells, and fibroblasts. Similarly, expression of CCL5 can be induced in activated T cells, macrophages, fibroblasts, epithelial and endothelial cells, and mesanglial cells , . Although chemokines evolved to benefit the host, inappropriate regulation or utilization of these proteins can contribute to many diseases .
Both CCL3 and CCL5 bind to receptors CCR1, CCR5 and to chemokine decoy receptor D6. CCL5 also binds to CCR3 . Genes ccl3 and ccl5 are situated on mouse chromosome 11; genes ccr1, ccr5 and ccbp2 (D6) are located on mouse chromosome 9 (Table S1). In CcS-16 ccl5 is on a STS-derived segment, whereas the strain of origin of ccl3 is not yet known; ccr1, ccr5 and ccbp2 are on BALB/c-derived segment ( and unpublished data).
The role of CC-chemokines CCL2, CCL3 and CCL5 in leishmaniasis has been tested in a number of studies (reviewed in , ). CCL2 and CCL3 stimulate anti-leishmania response via the induction of NO-mediated regulatory mechanisms to control the intracellular growth and multiplication of L. donovani . CCL2 together with CCL3 also significantly enhanced parasite killing in L. infantum infected human macrophages . In analysis of susceptibility to L. major in mouse, CCL5 contributed to host resistance, but CCL2 alone did not correlate with resistance . In humans, CCL2 expression correlated with self healing cutaneous lesions, whereas CCL3 was associated with lesions of chronic progressive diffuse cutaneous leishmaniasis caused by L. mexicana . These studies indicate that a coordinated interaction of several chemokines is important for successful immune response against Leishmania, but also that the role of different chemokines in defense against various Leishmania ssp. might differ. The observed strain differences and the double peak of CCL3 and CCL5 in CcS-16 females provide a novel potential starting point for investigation of the impact of inter-individual differences in chemokine response on pathogenesis of leishmaniasis.
L. tropica parasites are present in lymph nodes of all strains, but in much lower numbers than in mice infected with L. major
In spite of relatively limited pathological symptoms, we found viable parasites in inguinal lymph nodes of all tested strains (Figure 3, 4). In some strains (CcS-3, -18, -20 females, and CcS-20 and BALB/c males) we also observed visceralization of parasites in the spleen (Figure 5); and in females and males of BALB/c, CcS-3, CcS-11, CcS-16, CcS-18 and CcS-20 we detected parasites in the liver. Similarly as in previous L. major experiments, which mapped genes controlling parasite numbers and demonstrated their distinctness from susceptibility genes , our present L. tropica studies confirmed that the extent of the pathological changes in different organs did not directly correlate with parasite load. This was especially obvious in CcS-3 mice, which were resistant to development of skin pathology, but nevertheless contained parasites in lymph nodes, spleen and liver. These data indicate that parasite spread to the different organs and other manifestations of the disease are dependent on the genome of the host. Absence of correlation between parasite load in organs or parasitemia and intensity of disease has been observed also after infection with several other pathogens such as Toxoplasma gondii , Trypanosoma brucei brucei , Trypanosoma congolense , and Plasmodium berghei .
In conclusion, the present observation that many of the RC strains tested with the two Leishmania species exhibited different susceptibility to L. major and L. tropica demonstrates existence of species-specific controlling host genes with different functions. Therefore, without combining the two components of variation involved in the outcome of Leishmania infection – genetic variation of the host and species of the parasite - the understanding of the mechanisms of disease will remain incomplete. On the basis of the observed strain differences we will perform linkage analysis of the responsible genes. This information may provide the first step to distinguishing the species-specific from the general genes controlling pathogenesis of leishmaniasis.
Parasites in hematoxylin-eosin stained lymph node smears. All tested mice contained viable parasites in their inguinal lymph nodes. Infected BALB/c female (A); noninfected control BALB/c female (B); infected BALB/c male (C); noninfected control BALB/c male (D); infected STS female (E); noninfected control STS female (F); infected STS male (G); noninfected control STS male (H). Parasites are shown with arrows.
ID numbers for genes of chemokines and cytokines. ID numbers of genes, whose products were analyzed in this study, are shown.
Conceived and designed the experiments: TK HH M. Svobodová ML. Performed the experiments: TK HH IG JV M. Slapničková IK YS M. Svobodová. Analyzed the data: TK HH VV PD ML. Wrote the paper: TK PD ML.
- 1. Rittig MG, Bogdan C (2000) Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 16: 292–297.
- 2. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13: 151–177.
- 3. McMahon-Pratt D, Alexander J (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206–224.
- 4. Farrell JP (2002) Leishmania. Boston, Dordrecht, London: Kluwer Academic Publishers. 193 p.
- 5. Kobets T, Grekov I, Lipoldová M (2012) Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem 19: 1443–1474.
- 6. Herwaldt BL (1999) Leishmaniasis. Lancet 354: 1191–1199.
- 7. Lipoldová M, Demant P (2006) Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet 7: 294–305.
- 8. Jacobson RL (2003) Leishmania tropica (Kinetoplastida: Trypanosomatidae) - a perplexing parasite. Folia Parasit 50: 241–250.
- 9. Svobodova M, Votypka J, Peckova J, Dvorak V, Nasereddin A, et al. (2006) Distinct transmission cycles of Leishmania tropica in 2 adjacent foci, Northern Israel. Emerg Infect Dis 12: 1860–1868.
- 10. Magill AJ, Grögl M, Gasser RA Jr, Sun W, Oster CN (1993) Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328: 1383–1387.
- 11. Sacks DL, Kenney RT, Kreutzer RD, Jaffe CL, Gupta AK, et al. (1995) Indian kala-azar caused by Leishmania tropica. Lancet 345: 959–961.
- 12. Alborzi A, Pouladfar GR, Fakhar M, Motazedian MH, Hatam GR, et al. (2008) Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Am J Trop Med Hyg 79: 435–437.
- 13. Lira R, Méndez S, Carrera L, Jaffe C, Neva F, et al. (1998) Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 89: 331–342.
- 14. Girginkardeşler N, Balcioğlu IC, Yereli K, Özbilgin A, Özbel Y, et al. (2001) Cutaneous leishmaniasis infection in BALB/c mice using a Leishmania tropica strain isolated from Turkey. J Parasitol 87: 1177–1178.
- 15. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845–858.
- 16. Anderson CF, Lira R, Kamhawi S, Belkaid Y, Wynn TA, et al. (2008) IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J Immunol 180: 4090–4097.
- 17. Demant P, Hart AAM (1986) Recombinant congenic strains – a new tool for analysing genetic traits determined by more than one gene. Immunogenetics 24: 416–422.
- 18. Demant P, Lipoldová M, Svobodová M (1996) Resistance to Leishmania major in mice. Science 274: 1392–1393.
- 19. Lipoldová M, Svobodová M, Krulová M, Havelková H, Badalová J, et al. (2000) Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun 1: 200–206.
- 20. Vladimirov V, Badalová J, Svobodová M, Havelková H, Hart AAM, et al. (2003) Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice. Infect Immun 71: 2041–2046.
- 21. Havelková H, Badalová J, Svobodová M, Vojtíšková J, Kurey I, et al. (2006) Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun 7: 220–233.
- 22. Kurey I, Kobets T, Havelková H, Slapničková M, Quan L, et al. (2009) Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Immunogenetics 61: 619–633.
- 23. Stassen AP, Groot PC, Eppig JT, Demant P (1996) Genetic composition of the recombinant congenic strains. Mamm Genome 7: 55–58.
- 24. Grekov I, Svobodová M, Nohýnková E, Lipoldová M (2011) Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium. J Microbiol Methods 87: 273–277.
- 25. Rogers ME, Ilg T, Nikolaev AV, Ferguson MAJ, Bates PA (2004) Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 430: 463–467.
- 26. Titus RG, Marchand M, Boon T, Louis JA (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7: 545–555.
- 27. Kobets T, Badalová J, Grekov I, Havelková H, Svobodová M, et al. (2010) Leishmania parasite detection and quantification using PCR-ELISA. Nat Protoc 5: 1074–1080.
- 28. Lipoldová M, Svobodová M, Havelková H, Krulová M, Badalová J, et al. (2002) Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 54: 174–183.
- 29. Howard JG, Hale C, Chan-Liew WL (1980) Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol 2: 303–314.
- 30. Longley R, Smith C, Fortin A, Berghout J, McMorran B, et al. (2011) Host resistance to malaria: using mouse models to explore the host response. Mamm Genome 22: 32–42.
- 31. Lipoldová M, Kosařová M, Zajícová A, Holáň V, Hart AA, et al. (1995) Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics 41: 301–311.
- 32. Holáň V, Lipoldová M, Demant P (1996) Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2. Immunogenetics 44: 27–35.
- 33. Havelková H, Badalová J, Demant P, Lipoldová M (2000) A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA. Genes Immun 1: 483–487.
- 34. Lipoldová M, Havelková H, Badalová J, Demant P (2005) Novel loci controlling lymphocyte proliferative response to cytokines and their clustering with loci controlling autoimmune reactions, macrophage function and lung tumor susceptibility. Int J Cancer 114: 394–399.
- 35. Havelková H, Holáň V, Kárník I, Lipoldová M (2006) Mouse model for analysis of non-MHC genes that influence allogeneic response: recombinant congenic strains of OcB/Dem series that carry identical H2 locus. Cent Eur J Biol 1: 16–28.
- 36. Šíma M, Havelková H, Quan L, Svobodová M, Jarošíková T, et al. (2011) Genetic control of resistance to Trypanosoma brucei brucei infection in mice. PLoS Negl Trop Dis 5: e1173.
- 37. Shockley KR, Churchill GA (2006) Gene expression analysis of mouse chromosome substitution strains. Mamm Genome 17: 598–614.
- 38. Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, et al. (2003) Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 35: 357–362.
- 39. Alexander J (1988) Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major. Parasitology 96(Pt 2): 297–302.
- 40. Mock BA, Nacy CA (1988) Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun 56: 3316–3319.
- 41. Giannini MS (1986) Sex-influenced response in the pathogenesis of cutaneous leishmaniasis in mice. Parasite Immunol 8: 31–37.
- 42. Alexander J, Irving K, Snider H, Satoskar A (2010) Sex hormones of host responses against parasites. In: Klein SL, Roberts CW, editors. Sex hormons and immunity to infection. pp. 147–186. Springer Heildelberg, Dordrecht, London, New York, 2010.
- 43. Sakthianandeswaren A, Curtis JM, Elso C, Kumar B, Baldwin TM, et al. (2010) Fine mapping of Leishmania major susceptibility locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun 78: 2734–2744.
- 44. Lee AH, Hong JH, Seo YS (2000) Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 350 Pt 1: 131–138.
- 45. Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25: 787–820.
- 46. Teixeira JM, Teixeira CR, Andrade BB, Barral-Netto M, Barral A (2006) Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol 22: 32–40.
- 47. Oghumu S, Lezama-Davila CM, Isaac-Marquez AP, Satoskar AR (2010) Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol 126: 389–396.
- 48. Battacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, et al. (2002) Chemokine-induced leishmanicidal activity in murine macrophages via generation of nitric oxide. J Infect Dis 185: 1704–1708.
- 49. Brandonisio O, Panaro MA, Fumarola L, Sisto M, Leogrande D, et al. (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1α induce nitric oxide release and enchance parasite killing in Leishmania infantum-infected macrophages. Clin Exp Med 2: 125–129.
- 50. Da Costa Santiago H, Ferreira Oliveira C, Santiago L, Oliveira Ferraz F, de Glória de Souza D, et al. (2004) Involvement of chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun 72: 4918–4923.
- 51. Ritter U, Moll H, Laskay T, Brocker E, Velazco O, et al. (1996) Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 173: 699–709.
- 52. Johnson J, Suzuki Y, Mack D, Mui E, Estes R, et al. (2002) Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol 32: 179–185.
- 53. Masocha W, Amin DN, Kristensson K, Rottenberg ME (2008) Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL/6 and 129Sv/Ev mice. Scand J Immunol 68: 484–491.
- 54. Rathkolb B, Noyes HA, Brass A, Dark P, Fuchs H, et al. (2009) Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection. Infect Immun 77: 3948–3957.
- 55. Helegbe GK, Yanagi T, Senba M, Huy NT, Shuaibu MN, et al. (2011) Histopathological studies in two strains of semi-immune mice infected with Plasmodium berghei ANKA after chronic exposure. Parasitol Res 108: 807–814.